Yeshiva World News Dr. Makary: Most FDA-Approved Drugs Target Rare Diseases
“The majority of drugs that we approve are for rare diseases,” Dr. Makary said, as he outlined the FDA’s new framework for rare disease treatments.
“The majority of drugs that we approve are for rare diseases,” Dr. Makary said, as he outlined the FDA’s new framework for rare disease treatments.